Angeliq

Medicinal product

(Invented) name

Angeliq

Active substance (s)

Estradiolis/Drospirenonas

Strength

1 mg/2 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03FA17, Drospirenone and estrogen

Marketing authorisation holder

Bayer AG, Vokietija

Date of authorisation

2005-05-18

Date of renewal

2010-08-13

Documents

0220 Pakuotės lapelis 2024 01 30.docx

0220 Angeliq PCS PL 2024 01 30.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10b

Procedure number

NL/H/0380/001/MR

Marketing authorisation procedure

Savitarpio pripažinimo procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Estradiolis	1 mg
Drospirenonas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
13436	17736	1017736	lizdinė plokštelė	N1x28		Receptinis	LT/1/05/0220/001	Tiekiama	2024-11-21	-	No	-	-	Download
13437	17737	1017737	lizdinė plokštelė	N3x28		Receptinis	LT/1/05/0220/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-08-13	Perregistruotas
2005-05-18	Registruotas